Reasons for Early Removal of the Etonogestrel Subdermal Implant in Obese Women

被引：0
|
作者：
Hatch, Cherise [1 ]
Brouse, Brynne [1 ]
Young, Amanda [1 ]
Gray, Celia M. [1 ]
Paglia, Michael J. [1 ]
Howard, Denise [1 ]
机构：
[1] Geisinger, Danville, PA USA
来源：
OBSTETRICS AND GYNECOLOGY | 2022年 / 139卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
A35
引用
收藏
页码：11S / 11S
页数：1
相关论文
共 50 条
  • [31] A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant
    Apter, Dan
    Briggs, Paula
    Tuppurainen, Marjo
    Grunert, Julia
    Lukkari-Lax, Eeva
    Rybowski, Sarah
    Gemzell-Danielsson, Kristina
    FERTILITY AND STERILITY, 2016, 106 (01) : 151 - +
  • [32] A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon®
    Weisberg, Edith
    Croxatto, Horatio B.
    Findlay, John K.
    Burger, Henry G.
    Fraser, Ian S.
    CONTRACEPTION, 2011, 84 (06) : 600 - 608
  • [33] Effect of etonogestrel subdermal contraceptive implant (Implanon®) on liver function tests -: a randomized comparative study with Norplant® implants
    Biswas, A
    Biswas, S
    Viegas, OAC
    CONTRACEPTION, 2004, 70 (05) : 379 - 382
  • [34] Etonogestrel-releasing subdermal contraceptive implant: Budget impact analysis based on the Brazilian private healthcare system
    da Silva Filho, Agnaldo Lopes
    Pereira Bueno, Ricardo Luis
    Ramires, Yohanna
    Cruz Lino, Lara Marina
    PLOS ONE, 2024, 19 (03):
  • [35] Migration of a subdermal contraceptive implant into a subsegmental pulmonary artery and etonogestrel serum concentration over time - a case report
    Mallak, Farhad Kafi
    Kallner, Helena Kopp
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2022, 27 (03): : 261 - 264
  • [36] Risk of early etonogestrel and levonorgestrel implant discontinuation in adolescents and adults
    Chandi, Chotika
    Uaamnuichai, Sutira
    Phutrakool, Phanupong
    Wongwikrom, Watsapol
    Puapornpong, Pada
    Kaewthawon, Nanthida
    Jaisamrarn, Unnop
    Santibenchakul, Somsook
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [37] Continuation of the Etonogestrel Implant in Women Undergoing Immediate Postabortion Placement
    Madden, Tessa
    Eisenberg, David L.
    Zhao, Qiuhong
    Buckel, Christina
    Secura, Gina M.
    Peipert, Jeffrey F.
    OBSTETRICS AND GYNECOLOGY, 2012, 120 (05): : 1053 - 1059
  • [38] Effect of the subdermal contraceptive etonogestrel implant (Implanon®) on biochemical and hormonal parameters (three years follow-up)
    Inal, M. Murat
    Yildirim, Yusuf
    Ertopcu, Kenan
    Avci, M. Eftal
    Ozelmas, Isa
    Tinar, Sivekar
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2008, 13 (03): : 238 - 242
  • [39] CONTINUATION OF THE ETONOGESTREL IMPLANT IN WOMEN UNDERGOING IMMEDIATE POSTABORTION PLACEMENT
    Madden, T.
    Eisenberg, D.
    Zhao, Q.
    Buckel, C.
    Secura, G.
    Peipert, J.
    CONTRACEPTION, 2012, 86 (03) : 295 - 295
  • [40] Etonogestrel levels in normal-weight, overweight and obese women after 1 year or more of contraceptive implant use
    Morrell, K. M.
    Cremers, S.
    Westhoff, C.
    Davis, A. R.
    CONTRACEPTION, 2014, 90 (03) : 292 - 293
12345